Adiuvo Investments S.A. (ADV.WA)
PLN 0.36
(2.0%)
PLN 0.36
(2.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.2 Million PLN | -73.03% |
| 2022 | 8.18 Million PLN | -85.55% |
| 2021 | 56.61 Million PLN | -20.3% |
| 2020 | 71.02 Million PLN | -6.45% |
| 2019 | 75.92 Million PLN | -8.25% |
| 2018 | 82.75 Million PLN | 23.65% |
| 2017 | 66.92 Million PLN | -31.46% |
| 2016 | 97.64 Million PLN | 13.38% |
| 2015 | 86.12 Million PLN | 59.73% |
| 2014 | 53.91 Million PLN | 220.24% |
| 2013 | 16.83 Million PLN | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.08 Million PLN | -32.12% |
| 2024 Q1 | 1.59 Million PLN | -27.88% |
| 2023 Q2 | 9.21 Million PLN | 1.6% |
| 2023 FY | 2.2 Million PLN | -73.03% |
| 2023 Q4 | 2.2 Million PLN | -73.43% |
| 2023 Q3 | 8.3 Million PLN | -9.85% |
| 2023 Q1 | 9.06 Million PLN | 10.82% |
| 2022 FY | 8.18 Million PLN | -85.55% |
| 2022 Q1 | 59.04 Million PLN | 4.3% |
| 2022 Q4 | 8.18 Million PLN | -84.78% |
| 2022 Q3 | 53.76 Million PLN | -4.9% |
| 2022 Q2 | 56.53 Million PLN | -4.25% |
| 2021 Q4 | 56.61 Million PLN | 1.68% |
| 2021 FY | 56.61 Million PLN | -20.3% |
| 2021 Q2 | 57.73 Million PLN | -22.36% |
| 2021 Q1 | 74.36 Million PLN | 4.7% |
| 2021 Q3 | 55.67 Million PLN | -3.57% |
| 2020 Q4 | 71.02 Million PLN | -8.87% |
| 2020 Q3 | 77.94 Million PLN | -1.46% |
| 2020 Q1 | 76.69 Million PLN | 1.01% |
| 2020 FY | 71.02 Million PLN | -6.45% |
| 2020 Q2 | 79.09 Million PLN | 3.14% |
| 2019 Q2 | 84.58 Million PLN | -8.16% |
| 2019 Q3 | 83.04 Million PLN | -1.82% |
| 2019 Q4 | 75.92 Million PLN | -8.57% |
| 2019 FY | 75.92 Million PLN | -8.25% |
| 2019 Q1 | 92.09 Million PLN | 11.29% |
| 2018 Q4 | 82.75 Million PLN | -1.59% |
| 2018 FY | 82.75 Million PLN | 23.65% |
| 2018 Q3 | 84.09 Million PLN | 1.29% |
| 2018 Q2 | 83.01 Million PLN | 5.1% |
| 2018 Q1 | 78.98 Million PLN | 18.02% |
| 2017 Q1 | 99.24 Million PLN | 1.65% |
| 2017 FY | 66.92 Million PLN | -31.46% |
| 2017 Q4 | 66.92 Million PLN | -38.0% |
| 2017 Q3 | 107.95 Million PLN | -1.31% |
| 2017 Q2 | 109.39 Million PLN | 10.22% |
| 2016 FY | 97.64 Million PLN | 13.38% |
| 2016 Q4 | 97.64 Million PLN | -3.09% |
| 2016 Q2 | 86.28 Million PLN | 7.94% |
| 2016 Q1 | 79.94 Million PLN | -7.18% |
| 2016 Q3 | 100.75 Million PLN | 16.77% |
| 2015 Q1 | 60.7 Million PLN | 12.58% |
| 2015 Q2 | 70.36 Million PLN | 15.92% |
| 2015 Q4 | 86.12 Million PLN | 27.95% |
| 2015 Q3 | 67.3 Million PLN | -4.34% |
| 2015 FY | 86.12 Million PLN | 59.73% |
| 2014 Q4 | 53.91 Million PLN | 0.0% |
| 2014 FY | 53.91 Million PLN | 220.24% |
| 2013 FY | 16.83 Million PLN | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Genomtec S.A. | 16.04 Million PLN | 86.254% |
| Medinice S.A. | 37.49 Million PLN | 94.116% |
| Medicalgorithmics S.A. | 121.63 Million PLN | 98.186% |
| Synektik Spólka Akcyjna | 297.32 Million PLN | 99.258% |